Keith Krebs, the Senior Vice President, Product Development talks about NantHealth’s Core Value of Clarity.
The current climate has put many industries under a microscope, and healthcare is no exception. As the country continues to...
Study demonstrates the viability and value of RNA sequencing from formalin fixed samples in gaining a deeper understanding of patient...
Our Customer Success team is vital to our company. Their steadfast north star goal is to be the “voice of...
Q3 2020 Financial Highlights: Total net revenue was $18.8 million, up from $18.6 million Total software-related revenue increased to $18.7...
Employee engagement is a key factor in employee satisfaction and corporate growth. I am Elizabeth Diefendorf, Director of Training at...
Culver City, Calif. – October 30, 2020 — NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses...
In the previous entry in this blog series, we discussed healthcare datasets, their limitations, and how that impacts the practice...
Nanthealth Inc., Nantomics LLC and Immunitybio Inc., all of Culver City, Calif., developed image-based risk models for tumors using images from 82 pancreatic...
NantHealth, ImmunityBio and NantOmics Presented Results at the 2020 AACR Virtual Special Conference: Pancreatic Cancer Culver City, CA – October...
If there is a silver lining to the pandemic, it is that health systems have demonstrated an ability to be...
Dr. Bobby Reddy discusses the impact of the COVID-19 pandemic on the care of cancer patients, including changes to treatment...